LOUISBOURG INVESTMENTS INC.

Position in DFTX — Definium Therapeutics, Inc.

CIK 2053050 DIEPPE, A3

Position in DFTX

as of Mar 31, 2026 · filed Apr 22, 2026 Compact

Position Value

$982

New position

Shares Held

52

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOUISBOURG INVESTMENTS INC. holds $41,332 across 5 Biotechnology names.

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	502	$28,147
2	CRSP	CRISPR Therapeutics AG	80	$4,363
3	NTLA	Intellia Therapeutics, Inc.	200	$3,384
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6	$2,980
5	RXRX	Recursion Pharmaceuticals, Inc.	670	$2,458

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$982	52	—	Shares	Sole	2026-04-22
No filing history on record for this holder in this stock.